Cyber Monday Deal: Up to 60% off InvestingProCLAIM SALE

Asian scientists race to make Zika test kit, but lack of live sample a challenge

Published 10/02/2016, 13:25
Updated 10/02/2016, 13:30
© Reuters. Patricia Araujo, 23, who is seven months pregnant, stands in front of her stilt house, a lake dwelling also known as palafitte or 'Palafito', in Recife

By Aditya Kalra and Rujun Shen

NEW DELHI/SINGAPORE (Reuters) - Scientists in Asia are racing to put together detection kits for the Zika virus, with China on Thursday confirming its first case, but the researchers are challenged by the lack of a crucial element - a live sample of the virus.

Zika, suspected of causing brain defects in more than 4,000 newborns in Brazil after spreading through much of the Americas, is a particular worry in South and Southeast Asia, where mosquito-borne tropical diseases such as dengue fever are a constant threat.

India is working on diagnostic kits for the virus, as there is no testing kit commercially available in the world's second populous country, but the lack of a live virus sample is hindering its efforts.

A strain from 1950 was found dead and not suitable for research, said Soumya Swaminathan, director general of the state-run Indian Council of Medical Research (ICMR), which spearheads biomedical research.

"We want it for our research," Swaminathan said, referring to live samples of the virus. "In a big country like India, we need it."

India has written to international agencies, the World Health Organisation among them, seeking a sample of live Zika virus, the council says.

"If we get it, we can develop a kit and testing procedures within a month," said a council official, who declined to be identified because of lack of authorisation to speak to the media.

In the affluent city state of Singapore, scientists are working on a diagnostic kit to simultaneously detect Zika, dengue and chikungunya viruses, which are transmitted by the same type of mosquitoes and cause similar symptoms.

Singapore, which is just north of the equator, has suffered a spike in cases of dengue fever this year, and has taken precautions against a Zika outbreak.

"Every country and major city needs to be prepared," said Sebastian Maurer-Stroh, director of the infectious diseases programme at the Bioinformatics Institute of A*Star, Singapore's public sector research agency.

The new kit developed by Maurer-Stroh's team would save two thirds of the cost and time needed to test for the three viruses individually, and can be run on standard hospital equipment.

The new kit is expected to be distributed to hospitals by the end of March, where it will undergo final testing on real viruses, if Zika eventually hits the shores of Singapore.

© Reuters. Patricia Araujo, 23, who is seven months pregnant, stands in front of her stilt house, a lake dwelling also known as palafitte or 'Palafito', in Recife

"It is a challenge to get the information as well as access to all samples and sequences, and that's a challenge that everyone in the world faces," said Maurer-Stroh.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.